Skip to content

Observation of plasma pancreatic peptide concentration in patients with type 2 diabetes, IGT and obesity

Observation of plasma pancreatic peptide concentration in patients with type 2 diabetes, IGT and obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCH-12002763
Enrollment
Unknown
Registered
2012-12-05
Start date
2011-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

four:Measure pp level

Sponsors

Endocrinology of Zhujiang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 45 Years

Inclusion criteria

Inclusion criteria: Male, 40-45 in ages, BMI>=26, trail was divided into 4 groups: single obeseIGTtype 2 diabeteshealthy group. Each group has no smoking history, no cardiovascular diseases, no respiration dise-ses, and digestive diseases etc., without liver and kidney dysfunction,and history of other endocrine and metabolic disease,and no effecting on pancreatic polypeptide.

Exclusion criteria

Exclusion criteria: Female, younger than 40 and older than 45 in ages, BMI<26, smoking, in diseases with cardiovascul , respiration and digestion, liver and kidney dysfunction, and history of other endocrine and metabolic disease.

Design outcomes

Primary

MeasureTime frame
Pancreatic polypeptid;

Countries

China

Contacts

Public ContactDehong Cai
cai_de_hong@126.com+86 13808843648

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026